Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1039620140040020164
Korean Journal of Family Practice
2014 Volume.4 No. 2 p.164 ~ p.170
Compliance of Hyperlipidemia Medication and Related Factors in a Health Screening Center
Bae Ri-Ah

Cheong Yoo-Seock
Park Eal-Whan
Choi Eun-Young
Seo Sang-Wook
Abstract
Background: Hyperlipidemia is well known risk factor for coronary heart disease. Persistence with lipid-lowering drug therapy in Korea has not been studied much previously. This study was designed to determine the rate at which patients with hyperlipidemia persist in taking lipid-lowering agents, and to analyze related factors in a health screening center.

Methods: This was a retrospective study that utilized data from the heath screening center in a university hospital to analyze persistence rates with statins. The study included data for 150 patients who started lipid-lowering therapy between January 2011, and February 2012. Main outcome measures included the percentage of patients persisting in therapy for the fi rst 4 weeks and mean of medication days.

Results: The percentage of patients who persisted with overall statin therapy was 52% after 1 month. Persistence was better in elderly patients, non-smokers, regular exercisers, and patients with good knowledge of hyperlipidemia. The main reason for discontinuation is burden of life-long medication (48.6%).

Conclusion: Persistence with statin therapy by patients in a Korean health screening center was low compared with other clinical settings. Low persistence may have negated potential clinical benefi ts of long-term statin therapy.
KEYWORD
Hyperlipidemias, Lipid Lowering Drug, Compliance
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) ´ëÇÑÀÇÇÐȸ ȸ¿ø